$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$3.99M
Market Cap
0.0089
P/E Ratio
776.03
EPS
$114.00
52 Week High
$4.93
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
CNS Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Houston, Texas, focused on developing innovative therapies for brain and central nervous system tumors. The company is advancing its lead candidate aimed at addressing substantial unmet medical needs in oncology, particularly within neuro-oncology. Through a robust scientific foundation and strategic collaborations, CNS Pharmaceuticals is committed to enhancing patient outcomes and tackling the complexities of brain cancer treatment. With its pioneering approach, the company is positioning itself as a key player in the specialized field of neuro-oncology therapeutics.
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
PLTR
CDE
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
PLTR
CDE
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL